Table 2.
LN + | Prognosticator | P value |
Kuopio et al. 1998 [34] | ||
1. Bcl-2 | 0.017 | |
2. p53 | 0.121 | |
3. Cystatin A | 0.386 | |
Jalava et al. 2002 [16] | ||
1. ErbB2 | 0.0002 | |
2. SMI | 0.0014 | |
3. Bcl-2 | 0.048 | |
Elzagheid et al. 2002 [150] | ||
1. E-cadherin | 0.0006 | |
2. SMI | 0.0133 | |
LN - | ||
Kuopio et al. 1998 [34] | ||
1. Cystatin A | 0.010 | |
2. p53 | 0.021 | |
3. Bcl-2 | 0.874 | |
Jalava et al. 2002 [16] | ||
1. SMI | 0.0001 | |
2. ErbB2 | N.S. | |
3. Bcl-2 | N.S. | |
Elzagheid et al. 2002 [150] | ||
1. SMI | 0.0299 | |
2. E-cadherin | 0.5581 |
P values refer to the results of univariate analysis. Comparison of univariate analyses in a study allows one to conclude on the relative strengths of different prognosticators.